Iovance Biotherapeutics Inc.
IOVA | NASDAQ
$10.35
+$0.16 (+1.57%)
Sep 22, 2026, 10:58 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 110.77M | 196.51M | 163.08M | 158.13M | 132.47M | 171.67M | 115.69M | 164.19M | 228.75M | 134.19M | 114.89M | 267.72M | 230.01M | 543.48M | 231.73M | 118.37M | 108.08M | 92.36M | 78.23M | 58.59M | 82.76M | 131.95M |
Short-Term Investments | 186.91M | 116.94M | 133.9M | 142.67M | 168.71M | 188.05M | 208.09M | 233.3M | 183.86M | 222.01M | 164.98M | 93.65M | 20.88M | 82.81M | 240.11M | 241.81M | 316.38M | 389.83M | 426.18M | 517.86M | 573.61M | 461.98M |
Long-Term Investments | n/a | n/a | n/a | 5.97M | n/a | n/a | n/a | 6.36M | 6.36M | n/a | 66.43M | n/a | n/a | n/a | n/a | n/a | n/a | 27.7M | 91.59M | 78.25M | 46.29M | 10.23M |
Other Long-Term Assets | 12.44M | 14.28M | 14.15M | 9.27M | 16.26M | 6.25M | 6.73M | 280K | 327K | 6.69M | 270K | 66.71M | 66.72M | 6.63M | 6.62M | 7.03M | 7.29M | 7.35M | 7.87M | 7.1M | 7.23M | 7.25M |
Receivables | 102.12M | 81.76M | 82.45M | 66.76M | 59.94M | 70.94M | 69.34M | 55.77M | 31.6M | 234K | 151K | n/a | 33K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | 55.59M | 58.38M | 51.68M | 51.71M | 49.83M | 65.55M | 51.52M | 38.58M | 27.85M | 17.62M | 10.37M | 9.2M | 9.72M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 8.87M | 12.93M | 11.58M | 9.82M | 11.55M | 16.45M | 12.38M | 6.74M | 10.18M | 11.49M | 17.46M | 12.02M | n/a | 11.49M | 7.27M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 464.26M | 466.5M | 442.69M | 429.09M | 422.5M | 512.65M | 457.02M | 498.58M | 482.26M | 385.53M | 307.85M | 382.59M | 274.88M | 637.78M | 479.12M | 369.88M | 431.59M | 489.97M | 507.96M | 583.03M | 666.64M | 605.22M |
Property-Plant & Equipment | 174.94M | 175.78M | 177.01M | 175.41M | 172.42M | 162.49M | 164.28M | 179.26M | 180.08M | 183.31M | 176.55M | 179.41M | 180.18M | 180.35M | 178.25M | 169.01M | 172M | 176.23M | 169.92M | 160.46M | 132.63M | 127.88M |
Goodwill & Intangibles | 263.89M | 269.1M | 279.32M | 285.21M | 296.25M | 285.36M | 282.4M | 306.64M | 295.3M | 294.3M | 229.26M | 223.61M | 235.51M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 451.27M | 459.16M | 470.48M | 475.86M | 484.94M | 454.09M | 453.41M | 492.54M | 482.07M | 484.3M | 472.5M | 469.73M | 482.42M | 186.99M | 184.87M | 176.04M | 179.29M | 211.28M | 269.38M | 245.8M | 186.15M | 145.36M |
Total Assets | 915.53M | 925.67M | 913.17M | 904.95M | 907.44M | 966.74M | 910.43M | 991.12M | 964.32M | 869.83M | 780.35M | 852.32M | 757.29M | 824.77M | 663.98M | 545.92M | 610.88M | 701.25M | 777.33M | 828.83M | 852.79M | 750.57M |
Account Payables | 26.21M | 37.45M | 22.16M | 31.24M | 32M | 28.49M | 27.51M | 31.69M | 20.42M | 25.7M | 33.12M | 19.27M | 31.16M | 31.57M | 26.6M | 24.26M | 20.01M | 20.45M | 27.38M | 12.18M | 21.91M | 13.37M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | 1M | 4.04M | 1M | 1M | 1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | n/a | n/a | 112.16M | 4.36M | n/a | n/a | 50.03M | n/a | 36.81M | n/a | 34.59M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Liabilities | 106.85M | 129.42M | 138.36M | 125.79M | 129.16M | 122.69M | 122.34M | 118.06M | 93.64M | 83.21M | 110.31M | 90.96M | 88.64M | 87.27M | 91.49M | 79.25M | 64.19M | 77.08M | 89.2M | 64.77M | 60.53M | 55.06M |
Long-Term Debt | n/a | 43.88M | n/a | n/a | n/a | n/a | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 72.64M | 74.49M | 76.23M | 76.88M | 79.79M | 76.18M | 77.68M | 99.6M | 102.14M | 106.59M | 85.43M | 87.35M | 90.08M | 70.61M | 72.86M | 72.94M | 74M | 72.18M | 66.47M | 65.73M | 47.84M | 48.08M |
Total Liabilities | 179.49M | 203.91M | 214.59M | 202.66M | 208.95M | 198.88M | 200.02M | 217.66M | 195.78M | 189.81M | 195.74M | 178.31M | 178.72M | 157.89M | 164.34M | 152.19M | 138.19M | 149.26M | 155.67M | 130.5M | 108.38M | 103.14M |
Total Debt | 46M | 47.78M | 48.44M | 52.49M | 53.17M | 53.72M | 58.26M | 78.94M | 81.68M | 84.37M | 75.86M | 79.48M | 80.71M | 83.23M | 85.45M | 80.11M | 80.48M | 79.89M | 71.53M | 72.35M | 52.27M | 54M |
Book Value | 736.05M | 721.75M | 698.58M | 702.29M | 698.49M | 767.87M | 710.41M | 773.46M | 768.54M | 680.02M | 584.61M | 674.01M | 578.57M | 666.88M | 499.64M | 393.74M | 472.69M | 551.99M | 621.66M | 698.33M | 744.41M | 647.43M |
Book Value Per Share | 1.63 | 1.72 | 1.72 | 1.93 | 2.09 | 2.38 | 2.33 | 2.55 | 2.70 | 2.55 | 2.28 | 2.74 | 2.58 | 3.12 | 3.03 | 2.49 | 3.01 | 3.51 | 3.96 | 4.49 | 4.84 | 4.39 |
Common Stock | 19K | 18K | 17K | 16K | 14K | 14K | 13K | 13K | 12K | 12K | 11K | 11K | 9K | 9K | 8K | 7K | 7K | 7K | 7K | 7K | 7K | 6K |
Retained Earnings | -2.9B | -2.85B | -2.78B | -2.7B | -2.61B | -2.5B | -2.38B | -2.31B | -2.22B | -2.13B | -2.01B | -1.9B | -1.78B | -1.68B | -1.57B | -1.46B | -1.36B | -1.26B | -1.17B | -1.07B | -986.99M | -905.64M |
Comprehensive Income | 13.08M | 12.65M | 16.44M | 16.1M | 20.86M | 6.29M | -1.05M | 16.24M | 526K | 116K | 2.53M | -9.1M | 325K | -126K | -902K | -2.04M | -2.7M | -2.34M | -601K | -5K | 33K | 96K |
Shareholders Equity | 736.05M | 721.75M | 698.58M | 702.29M | 698.49M | 767.87M | 710.41M | 773.46M | 768.54M | 680.02M | 584.61M | 674.01M | 578.57M | 666.88M | 499.64M | 393.74M | 472.69M | 551.99M | 621.66M | 698.33M | 744.41M | 647.43M |
Total Investments | 186.91M | 116.94M | 133.9M | 148.63M | 168.71M | 188.05M | 208.09M | 239.66M | 190.22M | 222.01M | 231.41M | 93.65M | 20.88M | 82.81M | 240.11M | 241.81M | 316.38M | 417.53M | 517.77M | 596.11M | 619.89M | 472.2M |
Add to Watchlist
Select watchlists to add or remove IOVA